NCT06793085 Pro- and Anti-inflammatory Cytokines in PCOS
| NCT ID | NCT06793085 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jagiellonian University |
| Condition | Reproductive Age |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-20 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-01-20 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will involve measurements and comparisons of the concentrations of pro-inflammatory cytokines: IL-6, TNF-α, IL-18, as well as anti-inflammatory cytokine IL-4 in women with polycystic ovary syndrome (PCOS) and insulin resistance, women with polycystic ovary syndrome without carbohydrate metabolism disorders, and women without PCOS (control group).
Eligibility Criteria
Inclusion Criteria: * women aged 18-45 years Exclusion Criteria: * previous removal of at least one ovary * treated diabetes of any type * diagnosed and treated metabolic diseases * diagnosed and treated autoimmune diseases * diagnosed and treated autoinflammatory diseases
Contact & Investigator
Kazimierz Pityński, Prof., Ph.D., M.D.
STUDY CHAIR
Jagiellonian University
Frequently Asked Questions
Who can join the NCT06793085 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Reproductive Age. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06793085 currently recruiting?
Yes, NCT06793085 is actively recruiting participants. Contact the research team at iwona.gawron@uj.edu.pl for enrollment information.
Where is the NCT06793085 trial being conducted?
This trial is being conducted at Krakow, Poland.
Who is sponsoring the NCT06793085 clinical trial?
NCT06793085 is sponsored by Jagiellonian University. The principal investigator is Kazimierz Pityński, Prof., Ph.D., M.D. at Jagiellonian University. The trial plans to enroll 100 participants.